IMPACT OF INSULIN RESISTANCE ASSESSED BY THE HOMA2-IR MODEL ON THE SEVERITY OF CORONARY ARTERY DISEASE IN NON-DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROME

Nguyen Ngoc Minh Thu1,2, Bui The Dung1,3, Lam Vinh Nien1,3, Vu Hoang Vu
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Hong Bang International University
3 University Medical Center Ho Chi Minh City

Main Article Content

Abstract

Objective: This study aims to determine the prevalence of insulin resistance (HOMA2-IR) in non-diabetic patients with acute coronary syndrome and to evaluate its association with clinical characteristics, cardiac injury markers, the severity of coronary artery disease, and risk stratification parameters (GRACE and Gensini scores) during the acute phase.


Methods: A cross-sectional analytical study was conducted on 116 non-diabetic patients with acute myocardial infarction. Insulin resistance was defined as HOMA2-IR ≥ 1,35. Clinical characteristics, biochemical parameters, Gensini score, and GRACE score were collected and compared between the groups with and without insulin resistance.


Results: Among 116 non-diabetic patients with acute coronary syndrome, the prevalence of insulin resistance was 58.6%. Compared with the non-insulin-resistant group, patients with insulin resistance were younger (65.34 years vs. 70.75 years; p = 0.027), had a higher BMI (23.68 kg/m² vs. 21.75 kg/m²; p < 0.001), and exhibited significantly elevated fasting glucose and fasting insulin levels (p < 0.001). The insulin-resistant group also had higher systolic blood pressure, heart rate, and a greater proportion of patients with intermediate or high GRACE risk scores (p < 0.05). In addition, they had higher Gensini scores and longer lesion length (p < 0.05), increased hs-TroponinT and CK-MB levels (p = 0.03 and p = 0.04, respectively), and lower left ventricular ejection fraction (p = 0.02). Conversely, NT-proBNP levels did not differ significantly between the two groups.


Conclusion: In this study, insulin resistance assessed by HOMA2-IR was highly prevalent among non-diabetic patients with acute coronary syndrome and was associated with higher GRACE risk scores, more severe coronary atherosclerotic burden, and reduced left ventricular ejection fraction. These findings suggest that insulin resistance may serve as an accompanying marker of a higher cardiovascular risk profile in this patient population. However, given the cross-sectional study design, these associations are observational only and should be confirmed in large, multicenter cohort studies.

Article Details

References

[1] Farhan S, Redfors B et al. Relationship between insulin resistance, coronary plaque, and clinical outcomes in patients with acute coronary syndromes: an analysis from the PROSPECT study. Cardiovasc Diabetol, 2021, 20 (1): 10. doi: 10.1186/s12933-020-01207-0.
[2] Trần Thành Vinh, Lê Văn Thanh và cộng sự. Nghiên cứu tình trạng đề kháng insulin trên bệnh nhân tiền đái tháo đường bằng mô hình HOMA2 tại Bệnh viện Chợ Rẫy. Tạp chí Y học Việt Nam, 2024, 537 (1): 307-311. doi: 10.51298/vmj.v537i1.9054.
[3] Demir A.K, Şahin Ş et al. Prevalence of insulin resistance and identifying HOMA1-IR and HOMA2-IR indexes in the Middle Black Sea region of Turkey. African Health Sciences, 2020, 20 (1): 277-286. doi: 10.4314/ahs.v20i1.33.
[4] Lazzeri C, Sori A et al. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol, 2009, 26 (10): 856-62. doi: 10.1097/EJA.0b013e32832a235c.
[5] Kasem S.M, Saied G.M et al. Impact of acute insulin resistance on myocardial blush in non-diabetic patients undergoing primary percutaneous coronary intervention. Front Cardiovasc Med, 2021, 8: 647366. doi: 10.3389/fcvm.2021.647366.
[6] Strisciuglio T, Izzo R et al. Insulin resistance predicts severity of coronary atherosclerotic disease in non-diabetic patients. J Clin Med, 2020, 9 (7). doi: 10.3390/jcm9072144.
[7] Eid M, Sayed S.A et al. HOMA estimated insulin resistance as a marker for angiographic severity of coronary artery disease in non-diabetic and non-obese patients. Caspian J Intern Med, 2023, 14 (3): 495-506. doi: 10.22088/cjim.14.3.495.
[8] Al-Ali S.A, Alidrisi H.A et al. Correlation of insulin resistance with short-term outcome in nondiabetic patients with st-segment elevation myocardial infarction. Cureus, 2022, 14 (12): e33093. doi: 10.7759/cureus.33093.
[9] Trifunovic D, Stankovic S et al. Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovascular Diabetology, 2014, 13 (1): 73. doi: 10.1186/1475-2840-13-73.